Skip to main content

Table 2 End of treatment and early virological response in both groups

From: Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial

Treatment group

End of Treatment Response (6 months)

Total

Sig

  

non-ETR

p-ETR

c-ETR

  

Spirulina

Count

24

2

4

30

0.12

 

% within Treatment group

80%

6.7%

13.3%

100%

 

Silymarin

Count

28

0

1

29

 
 

% within Treatment group

96.6%

0%

3.4%

100%

 

Treatment group

Early Virological Response (3 months)

Total

Sig

  

non-EVR

p-EVR

c-EVR

  

Spirulina

Count

27

2

1

30

0.22

 

% within Treatment group

90%

6.7%

3.3%

100%

 

Silymarin

Count

29

0

0

29

 
 

% within Treatment group

100%

0%

0%

100%

Â